| 1. | | No longer recruiting | Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer
Conditions: Male Breast Cancer; stage IV breast cancer; recurrent breast cancer |
| 2. | | Recruiting | Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer
Conditions: stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum |
| 3. | | Suspended | BMS-214662 in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 4. | | No longer recruiting | Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
Conditions: Leukemia; Lymphoma; Multiple Myeloma |
| 5. | | Recruiting | Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
Condition: Head and Neck Cancer |
| 6. | | No longer recruiting | Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Condition: Head and Neck Cancer |
| 7. | | No longer recruiting | Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck
Conditions: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; ... |
| 8. | | No longer recruiting | Chemotherapy With or Without Docetaxel Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Conditions: stage III squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ... |
| 9. | | No longer recruiting | Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic Leukemia
Conditions: L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; cardiac toxicity; ... |
| 10. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
Conditions: stage II nasopharyngeal cancer; stage III nasopharyngeal cancer; stage IV nasopharyngeal cancer |
| 11. | | No longer recruiting | Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer
Conditions: Lung Cancer; Gastrointestinal Cancer; Reproductive Cancers; Head and Neck Cancer; Bone Cancer; Kaposi's Sarcoma; Soft Tissue Sarcoma |
| 12. | | Recruiting | Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation
Condition: veno-occlusive disease |
| 13. | | No longer recruiting | Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
Conditions: stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate |
| 14. | | Recruiting | Epirubicin and Thalidomide in Treating Patients With Liver Cancer
Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ... |
| 15. | | Completed | Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Conditions: adenocarcinoma of the prostate; recurrent prostate cancer |
| 16. | | Recruiting | Flavopiridol in Treating Patients With Metastatic or Unresectable Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Mesothelioma, Renal Cell Carcinoma (Kidney Cancer), Squamous Cell Carcinoma of the Head and Neck, Small Cell Lung Cancer, or Invasive Breast Cancer
Conditions: Breast Cancer; Head and Neck Cancer; hematopoietic and lymphoid cancer; kidney and urinary cancer; thorax and respiratory cancer |
| 17. | | Recruiting | Gemcitabine and Flavopiridol in Treating Patients With Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 18. | | No longer recruiting | Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery
Conditions: high-grade salivary gland carcinoma; low-grade salivary gland carcinoma; Salivary Gland Cancer |
| 19. | | No longer recruiting | Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 20. | | No longer recruiting | Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer
Conditions: lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer |
| 21. | | No longer recruiting | Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer
Conditions: stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate |
| 22. | | Completed | Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain
Conditions: Pain; unspecified adult solid tumor, protocol specific; Quality of Life |
| 23. | | Recruiting | Intrathecal and Systemic Chemotherapy Combined With Radiation Therapy in Treating Young Patients With Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumors
Condition: childhood rhabdoid tumor of the central nervous system |
| 24. | | Recruiting | KRN5500 in Treating Patients With Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 25. | | Recruiting | Letrozole in Preventing Breast Cancer in Postmenopausal Women
Conditions: Breast Cancer; breast cancer in situ |
| 26. | | No longer recruiting | Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease
Condition: Graft Versus Host Disease |
| 27. | | Recruiting | Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer
Conditions: recurrent breast cancer; stage IV breast cancer |
| 28. | | Recruiting | Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer
Conditions: acute leukemia; atypical chronic myeloid leukemia; Melanoma; myelodysplastic and myeloproliferative disease; Non-small cell lung cancer; ... |
| 29. | | No longer recruiting | Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain
Conditions: constipation, impaction, and bowel obstruction; unspecified adult solid tumor, protocol specific |
| 30. | | Recruiting | ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
Conditions: lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer |
| 31. | | No longer recruiting | Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia
Condition: Fanconi's Anemia |
| 32. | | Recruiting | PKC412 in Patients with Acute Myeloid Leukemia and Patients with Myelodysplastic Syndrome with either Wild Type or Mutated FLT3
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndromes |
| 33. | | No longer recruiting | Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer; stage IIIB breast cancer |
| 34. | | No longer recruiting | Rosiglitazone in Treating Patients With Liposarcoma
Conditions: adult liposarcoma; recurrent adult soft tissue sarcoma |
| 35. | | Recruiting | Safety and Efficacy of Atiprimod for Patients with Refractory Multiple Myeloma
Condition: Multiple Myeloma |
| 36. | | No longer recruiting | Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 37. | | Completed | SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas
Conditions: stage IVB adult soft tissue sarcoma; gastrointestinal stromal tumor; recurrent adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; ... |
| 38. | | Recruiting | Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Mixed Gliomas; adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma |
| 39. | | Recruiting | Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma
Conditions: adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; Mixed Gliomas |
| 40. | | Recruiting | Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer; Male Breast Cancer |
| 41. | | Recruiting | Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 42. | | No longer recruiting | Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer
Conditions: salivary gland malignant mixed cell type tumor; salivary gland poorly differentiated carcinoma; stage III salivary gland cancer; ... |
| 43. | | No longer recruiting | Troglitazone in Treating Patients With Liposarcoma
Conditions: adult liposarcoma; recurrent adult soft tissue sarcoma |
| 44. | | Recruiting | Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
Conditions: Brain Tumor; childhood brain tumor; childhood soft tissue sarcoma; gastrointestinal stromal tumor; Muscle Cancer |
| 45. | | No longer recruiting | Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: recurrent childhood acute lymphoblastic leukemia; recurrent adult acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; ... |
| 46. | | No longer recruiting | Vaccine Therapy in Treating Patients With Advanced Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer |
| 47. | | Recruiting | Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
Conditions: stage IV breast cancer; Male Breast Cancer; recurrent breast cancer |
| 48. | | No longer recruiting | Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 49. | | No longer recruiting | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
Conditions: stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer |
| 50. | | Recruiting | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Recurrent Melanoma; stage III melanoma; Stage IV Melanoma |
